Inventor · disambiguated record
Johannes Bange
Also filed as: BANGE JOHANNES
8 granted patents·1 pending application·97 citations·filing 1999–2015
87Inventor score
Top patents by PatentIndex Score
9 records- 0190US7297774B2Use of inhibitors for the treatment of RTK-hyperfunction-induced disorders, particularly cancerMAX PLANCK GESELLSCHAFT·Filed 2004·Granted Nov 20, 2007·26 cites·3 claims
- 0288US7531304B2Method for screening FGFR-4 agonistsMAX PLANCK GESELLSCHAFT·Filed 2003·Granted May 12, 2009·35 cites·9 claims
- 0385US8043806B2Method of diagnosing an RTK-hyperfunction induced disorderMAX PLANCK GESELLSCHAFT·Filed 2010·Granted Oct 25, 2011·7 cites·7 claims
- 0480US7678372B2Use of inhibitors for the treatment of RTK-hyperfunction-induced disorders, particularly cancerMAX PLANCK GESELLSCHAFT·Filed 2003·Granted Mar 16, 2010·7 cites·11 claims
- 0578US9284379B2FGFR4 antibodiesU3 PHARMA GMBH·Filed 2013·Granted Mar 15, 2016·2 cites·18 claims
- 0676US10358498B2Human anti-FGFR4 antibodyDAIICHI SANKYO EUROPE GMBH·Filed 2015·Granted Jul 23, 2019·4 cites·10 claims
- 0764US6770742B1Use of inhibitors for the treatment of disorders related to RTK hyperfunction, especially cancerMAX PLANCK GESELLSCHAFT·Filed 1999·Granted Aug 3, 2004·15 cites·1 claims
- 0858US8394927B2FGFR4 antibodiesBANGE JOHANNES·Filed 2007·Granted Mar 12, 2013·1 cites·15 claims
- 0944US2009123462A1Fgfr agonistsBANGE JOHANNES·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Johannes Bange files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →